Accelerating Drug Discovery Using the Next Generation of Humanized Immune System (HIS) Mice

In this exclusive webinar, Monika Buczek, PhD, explains how mice with human immune system features provide a platform for understanding human disease and advancing drug development, particularly in the fields of immuno-oncology and autoimmune disease. An expert in translational drug development, Dr. Buczek will detail how to identify and address common pitfalls associated with humanizing mice, such as donor variability. Dr. Buczek will also provide case studies, demonstrating how utilizing next-generation humanize immune system mice, with the use of Taconic’s new donor characterization and flow cytometry offerings, can improve results and reduce costs in the preclinical pipeline to advance drug development in cancer and autoimmunity.

Watch this webinar to learn about:

• How humanized mice are transforming research in immuno-oncology and autoimmune disease
• Strategies to address donor variability and improve reliability in humanized mouse models
• How Taconic’s next-generation humanized mice and flow cytometry offerings enhance accuracy, cut costs, and streamline preclinical research